Trials
Search / Trial NCT05640869

Diabetes Prevention Program to Treat Overweight and Obesity

Launched by AUBURN UNIVERSITY · Nov 28, 2022

Apply for Trial

Trial Information

Current as of February 05, 2025

Active, not recruiting

Keywords

Community Pharmacy

ClinConnect Summary

An estimated 38% percent of U.S. adults currently has prediabetes. In individuals aged 65 years and older, the prevalence of prediabetes is 48.8%. Prediabetes is commonly a precursor to the development of type 2 diabetes (t2d). Approximately 5-10% of individuals with prediabetes progress to t2d annually, with 70% developing t2d within their lifetime. Obesity is a significant risk factor for both prediabetes and diabetes, and its prevalence is steadily increasing. In 2020, a combined 66.7% of U.S. adults were classified as overweight or obese. In individuals with prediabetes, interventions l...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • • ≥18 years old
  • • BMI ≥ 25kg/m2 (23 if Asian)
  • Exclusion Criteria:
  • • Pregnancy

Trial Officials

Courtney E Gamston, PharmD

Principal Investigator

Auburn University Harrison School of Pharmacy

About Auburn University

Auburn University is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to interdisciplinary collaboration, the university leverages its diverse expertise in health sciences, engineering, and social sciences to conduct rigorous research that addresses pressing healthcare challenges. Auburn University’s Clinical Trials Office ensures adherence to ethical standards and regulatory compliance, facilitating high-quality research that contributes to the scientific community and enhances patient care. Through its robust infrastructure and support services, Auburn University is poised to make significant contributions to clinical research and public health advancements.

Locations

Auburn, Alabama, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials